Postinjury suppression of human neutrophil cytokine production results from the stabilization of inhibitory κB

Shock

Volumn 11, Issue 2, 1999, Pages 77-81

  Zallen, Garret ^a   Moore, Ernest E ^a   Johnson, Jeffrey L ^a   Tamura, Douglas Y ^a   Shames, Brian ^a   Biffl, Walter L ^a   Silliman, Christopher C ^a  

^a DENVER HEALTH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; DNA BINDING PROTEIN; FORMYLMETHIONYLLEUCYLPHENYLALANINE; I KAPPA B; IL1RN PROTEIN, HUMAN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; SIALOGLYCOPROTEIN; THROMBOCYTE ACTIVATING FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD; BLUNT TRAUMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; HUMAN; IN VITRO STUDY; METABOLISM; NEUTROPHIL; PENETRATING TRAUMA; POSTOPERATIVE COMPLICATION;

ADULT; CYTOKINES; DNA-BINDING PROTEINS; HUMANS; I-KAPPA B PROTEINS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-8; LIPOPOLYSACCHARIDES; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; NEUTROPHILS; PLATELET ACTIVATING FACTOR; POSTOPERATIVE COMPLICATIONS; SIALOGLYCOPROTEINS; TUMOR NECROSIS FACTOR-ALPHA; WOUNDS, NONPENETRATING; WOUNDS, PENETRATING;

EID: 0033072506     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-199902000-00001     Document Type: Article

References (32)

1. Rosenthal J, Thurman GW, Cusack N, Peterson VM, Malech HL, Ambruso DR: Neutrophils from patients after burn injury express a deficiency of the oxidase components p47-phox and p67-phox. Blood 88:4321-4329, 1996.
2. Vindenes HA, Bjerknes R: Impaired actin polymerization and depolymerization in neutrophils from patients with thermal injury. Burns 23:131-136, 1997.
3. Partrick DA, Moore FA, Moore EE, Barnett CC, Silliman CC: Neutrophil priming and activation in the pathogenesis of postinjury multiple organ failure. New Horiz 4:194-210, 1996.
4. Botha AJ, Moore FA, Moore EE, Sauaia A, Banerjee A, Peterson VM: Early neutrophil sequestration after injury: A pathogenic mechanism for multiple organ failure. J Trauma 39:411-417, 1995.
5. Botha AJ, Moore FA, Moore EE, Kim FJ, Banerjee A, Peterson VM: Postinjury neutrophil priming and activation: An early vulnerable window. Surgery 118:358-365, 1995.
6. Sauaia A, Moore FA, Moore EE, Haenel JB, Read RA: Pneumonia: Cause or symptom of postinjury multiple organ failure? Am J Surg 166:606-610, 1993.
7. Crump JM, Duncan DA, Wears R: Analysis of multiple organ system failure in trauma and nontrauma patients. Am Surg 54:702-708, 1988.
8. Faist E, Baue AE, Dittmer H, Heberer G: Multiple organ failure in polytrauma patients. J Trauma 23:775-787, 1983.
9. Manship L, McMillin RD, Brown JJ: The influence of sepsis and multi-system and organ failure on mortality in the surgical intensive care unit. Am Surg 50:94-101, 1984.
10. Cassatella MA: The production of cytokines by polymorphonuclear neutrophils. Immunol Today 16:21-26, 1995.
11. Damas P, Canivet JL, de Groote D, et al: Sepsis and serum cytokine concentrations. Crit Care Med 25:405-412, 1997.
12. Adamik B, Zimecki M, Wlaszczyk A, Kubler A: Immunological status of septic and trauma patients. II. Proliferative response and production of interleukin 6 and tumor necrosis factor alpha by peripheral blood mononuclear cells from septic survivor, nonsurvivor and trauma patients: A correlation with the survival rate. Arch Immunol Ther Exp 45:277-284, 1997.
13. Adamik B, Zimecki M, Wlaszczyk A, Kubler A: Immunological status of septic and trauma patients. I. High tumor necrosis factor alpha serum levels in septic and trauma patients are not responsible for increased mortality; a prognostic value of serum interleukin 6. Arch Immunol Ther Exp 45:169-175, 1997.
14. Seekamp A, Jochum M, Ziegler M, van Griensven M, Martin M, Regel G: Cytokines and adhesion molecules in elective and accidental trauma-related ischemia/reperfusion. J Trauma 44:874-882, 1998.
15. Shijo H, Iwabuchi K, Hosoda S, Watanabe H, Nagaoka I, Sakakibara N: Evaluation of neutrophil functions after experimental abdominal surgical trauma. Inflamm Res 47:67-74, 1998.
16. Wozniak A, Betts WH, Murphy GA, Rokicinski M: Interleukin-8 primes human neutrophils for enhanced superoxide anion production. Immunology 79:608-615, 1993.
17. Botha AJ, Moore FA, Moore EE, Peterson VM, Silliman CC, Goode AW: Sequential systemic platelet-activating factor and interleukin 8 primes neutrophils in patients with trauma at risk of multiple organ failure. Br J Surg 83:1407-1412, 1996.
18. Brandolini L, Bertini R, Bizzarri C, et al: IL-1 beta primes IL-8-activated human neutrophils for elastase release, phospholipase D activity, and calcium flux. J Leukoc Biol 59:427-434, 1996.
19. Meddows-Taylor S, Martin DJ, Tiemessen CT: Reduced expression of interleukin-8 receptors A and B on polymorphonuclear neutrophils from persons with human immunodeficiency virus type 1 disease and pulmonary tuberculosis. J Infect Dis 177:921-930, 1998.
20. Gabay C, Smith MF, Eidlen D, Arend WP: Interleukin 1 receptor antagonist (IL-1Ra) is an acute-phase protein. J Clin Invest 99:2930-2940, 1997.
21. Smith MF Jr, Eidlen D, Arend WP, Gutierrez-Hartmann A: LPS-induced expression of the human IL-1 receptor antagonist gene is controlled by multiple interacting promoter elements. J immunol 153:3584-3593, 1994.
22. Shakhov AN, Collart MA, Vassalli P, Nedospasov SA, Jongeneel CV: Kappa B-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor alpha gene in primary macrophages. J Exp Med 171:35-47, 1990.
23. Baldwin AS Jr: The NF-kappa B and I kappa B proteins: New discoveries and insights. Annu Rev Immunol 14:649-683, 1996.
24. McDonald PP, Bald A, Cassatella MA: Activation of the NF-kappaB pathway by inflammatory stimuli in human neutrophils. Blood 89:3421-3433, 1997.
25. Partrick D, Moore EE, Moore FA, Barnett C, Silliman C: Lipid mediators upregulate CD lib and prime for concordant superoxide and elastase release in human neutrophils. J Trauma 43:297-303, 1997.
26. Zallen G, Moore EE, Tamura DY, et al: Postinjury neutrophil priming in severely injured patients is mediated by p38 MAP kinase activation. Surg Forum, XLIX: 100, 1998.
27. Regnier CH, Song HY, Gao X, Goeddel DV, Cao Z, Rothe M: Identification and characterization of an IkappaB kinase. Cell 90:373-383, 1997.
28. Schwenger P, Alpert D, Skolnik EY, Vilcek J: Activation of p38 mitogen-activated protein kinase by sodium salicylate leads to inhibition of tumor necrosis factor-induced IkappaB alpha phosphorylation and degradation. Mol Cell Biol 18:78-84, 1998.
29. Schulze-Osthoff K, Ferrari D, Riehemann K, Wesselborg S: Regulation of NF-kappa B activation by MAP kinase cascades. Immunobiology 198:35-49, 1997.
30. Singh S, Darnay BG, Aggarwal BB: Site-specific tyrosine phosphorylation of IkappaBalpha negatively regulates its inducible phosphorylation and degradation. J Biol Chem 271:31049-31054, 1996.
31. Shames B, Selzman C, Meldrum D, et al: Interleukin-10 stabilizes Inhibitory κB-α in human monocytes. Shock 10:389-394, 1998.
32. Neidhardt R, Keel M, Steckholzer U, et al: Relationship of interleukin-10 plasma levels to severity of injury and clinical outcome in injured patients. J Trauma 42:863-870, 1997.